The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …

Abstract The International Consultations on Urological Diseases are international
consensus meetings, supported by the World Health Organization and the Union …

Activating mutations occur in the promoter of the telomerase reverse transcriptase (TERT)
gene in 66% of muscle-invasive urothelial carcinomas. To explore their role in bladder …

Objective To evaluate programmed death ligand 1 (PD-L1) expression in urothelial
carcinoma of the bladder in relationship with tumor-infiltrating CD8+ T cells. Materials and …

A uniform grading system for bladder cancer will allow for valid comparison of treatment
results among different centers. The introduction of the World Health Organization …

Simple Summary Bladder cancer (BC) is a common cancer that causes high morbidity and
mortality among affected patients. As a carcinogen-driven cancer, molecular oncology of BC …

Bladder cancer occurs in the epithelial lining of the urinary bladder and is amongst the most
common types of cancer in humans, killing thousands of people a year. This paper is based …

Purpose To investigate the feasibility of using CT texture analysis (CTTA) to differentiate
between low-versus high-grade urothelial carcinoma. Methods A total of 105 patients with …

Purpose Although cigarette smoking is a well established risk factor for urothelial cancer, its
role in urothelial cancer prognosis is still undetermined. In this meta-analysis we quantify the …

To assess the clinicopathological features and prognostic significance of the presence of 5%
or less high-grade component in otherwise low-grade noninvasive bladder urothelial …